세계의 기질 혈관 분획 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Stromal Vascular Fraction Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,052,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,300,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,994,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

주요 인사이트

• 기질 혈관 분획 시장 규모(2025년) : 1억 7,290만 달러
• 시장 규모 예측(2032년) : 2억 7,350만 달러
• 세계 시장 성장률(2025-2032년) : CAGR 5.2%

시장 성장 촉진요인:

세계 기질 혈관 분획 시장은 골관절염, 심혈관 질환, 자가면역질환과 같은 만성질환의 유병률 증가 등 몇 가지 주요 요인에 의해 주도되고 있으며, 이는 재생치료에 대한 수요를 자극하고 있습니다. 또한 면역 거부반응의 위험이 낮다는 장점으로 인해 자가 세포 기반 치료법의 채택이 증가하고 있으며, 이는 시장 확대를 더욱 촉진하고 있습니다. 효소 무첨가 및 자동 처리 시스템 등 SVF 분리 방법의 기술적 진보도 효율성을 높이고 처리 시간을 단축하여 SVF 치료법을 더욱 친숙하게 만들고 있습니다. 또한 줄기세포 연구 및 재생의료에 대한 정부 지원 증가와 생명공학 기업의 투자 증가도 이 시장의 성장을 가속하고 있습니다.

시장 기회:

기질 혈관 분획 시장에서는 새로운 용도에 대한 연구 증가, 적응증 확대, SVF 치료와 첨단 바이오기술의 융합 등으로 인해 큰 기회가 나타나고 있습니다. 신경질환, 창상 치유, 메디컬 에스테틱 분야에서 SVF의 잠재적 용도는 시장 범위를 넓히고 있습니다. 또한 SVF 유래 세포를 이용한 3D 바이오프린팅과 조직공학의 발전은 재생의료의 새로운 길을 열어가고 있으며, POC SVF 분리 시스템 개발 및 우수의약품 제조 및 품질관리기준(GMP) 준수 프로토콜의 채택도 시장 확대의 원동력이 될 것으로 예상됩니다. 생명공학 기업, 연구 기관, 의료 서비스 프로바이더 간의 전략적 제휴는 기술 혁신과 규제 당국의 승인을 가속화하여 시장의 지속적인 성장을 보장하는 데 필수적입니다.

세계의 기질 혈관 분획 시장을 조사했으며, 시장 정의와 개요, 시장 성장 촉진요인 및 억제요인, 각종 동향, 시장 기회와 과제, 시장 규모 추이와 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 시장 개요

• 시장의 범위·정의
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
  • 주요 동향
• 거시경제 요인
• COVID-19의 영향 분석
• 예측 요인 - 관련성과 영향

제3장 부가가치 인사이트

• 규제 상황
• 제품 채택 분석
• 밸류체인 분석
• 주요 거래와 합병
• PESTLE 분석
• Porter's Five Forces 분석

제4장 세계의 기질 혈관 분획 시장 전망

• 주요 하이라이트
• 시장 규모 분석과 예측
• 세계의 기질 혈관 분획 시장 전망 : 제품별
• 세계의 기질 혈관 분획 시장 전망 : 용도별
• 세계의 기질 혈관 분획 시장 전망 : 최종사용자별
  • 서론/주요 조사 결과
  • 과거 시장 규모 분석
  • 현재 시장 규모 분석·예측
  • 시장의 매력 분석

제5장 세계의 기질 혈관 분획 시장 전망 : 지역별

• 주요 하이라이트
• 과거 시장 규모 분석 : 지역별
• 현재 시장 규모 분석·예측 : 지역별
  • 북미
  • 유럽
  • 동아시아
  • 남아시아·오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역

제6장 북미의 기질 혈관 분획 시장 전망 :

제7장 유럽의 기질 혈관 분획 시장 전망 :

제8장 동아시아의 기질 혈관 분획 시장 전망 :

제9장 남아시아·오세아니아의 기질 혈관 분획 시장 전망 :

제10장 라틴아메리카의 기질 혈관 분획 시장 전망 :

제11장 중동 및 아프리카 기질 혈관 분획 시장 전망 :

제12장 경쟁 구도

• 시장 점유율 분석
• 시장 구조
• 기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
  • Cytori Therapeutics Inc.
  • IntelliCell BioSciences Inc.
  • Cellular Biomedicines Group, Inc.
  • GE Healthcare(Biosafe Group SA)
  • Lifecell Corporation(Allergen PLC)
  • Tissue Genesis Inc.
  • InGeneron, Inc.
  • Human med AG
  • MEDICAN CO., LTD
  • Hairline International
  • Genesis Biosystems, Inc.
  • iXCells Biotechnologies USA, LLC
  • Kyocera Corporation
  • Medikan International Inc.
  • Eurofins Scientific
  • Others

제13장 부록

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for stromal vascular fraction (SVF). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global stromal vascular fraction market from 2025 to 2032.

Key Insights:

• Stromal Vascular Fraction Market Size (2025E): US$ 172.9 Million
• Projected Market Value (2032F):US$ 273.5 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 5.2%

Stromal Vascular Fraction Market - Report Scope:

Stromal vascular fraction (SVF) is a rich source of regenerative cells, including mesenchymal stem cells (MSCs), pericytes, and endothelial cells, derived from adipose tissue. SVF has gained significant attention in regenerative medicine, with applications spanning orthopedics, dermatology, cardiology, and plastic surgery. The increasing demand for minimally invasive therapies, coupled with advancements in stem cell research, is fueling the growth of the SVF market. The market caters to hospitals, specialty clinics, and research institutes, offering a range of SVF isolation systems and enzymatic and non-enzymatic processing techniques.

Market Growth Drivers:

The global stromal vascular fraction market is driven by several key factors, including the rising prevalence of chronic diseases such as osteoarthritis, cardiovascular disorders, and autoimmune conditions, which are fueling the demand for regenerative therapies. The growing adoption of autologous cell-based therapies, due to their lower risk of immune rejection, is further propelling market expansion. Technological advancements in SVF isolation methods, such as enzyme-free and automated processing systems, are enhancing efficiency and reducing processing time, making SVF therapies more accessible. Additionally, increasing government support for stem cell research and regenerative medicine, along with growing investments from biotech companies, is fostering market growth.

Market Restraints:

Despite promising growth prospects, the stromal vascular fraction market faces challenges related to regulatory frameworks, high costs of cell isolation technologies, and ethical concerns surrounding stem cell therapies. Stringent regulatory guidelines governing the clinical use of SVF therapies vary across regions, affecting market adoption and commercial viability. Moreover, the need for specialized equipment and trained personnel increases the overall cost of SVF treatments, limiting their accessibility, particularly in developing economies. Additionally, the lack of long-term clinical data supporting the efficacy and safety of SVF-based treatments poses a challenge for widespread clinical adoption.

Market Opportunities:

The stromal vascular fraction market presents significant opportunities driven by increasing research into novel applications, expanding indications, and the integration of SVF therapies with advanced biotechnologies. The potential use of SVF in neurological disorders, wound healing, and aesthetic medicine is broadening the market scope. Moreover, advancements in 3D bioprinting and tissue engineering using SVF-derived cells are opening new avenues in regenerative medicine. The development of point-of-care SVF isolation systems and the adoption of good manufacturing practice (GMP)-compliant protocols are expected to drive market expansion. Strategic collaborations between biotech firms, research institutions, and healthcare providers are essential to accelerate innovation and regulatory approvals, ensuring sustained market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the stromal vascular fraction market globally?
• Which SVF isolation methods and applications are gaining prominence across different healthcare settings?
• How are technological advancements shaping the competitive landscape of the SVF market?
• Who are the key players contributing to the SVF market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global SVF market?

Competitive Intelligence and Business Strategy:

Leading players in the global stromal vascular fraction market, including Cytori Therapeutics, Tissue Genesis, Inc., and InGeneron, Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced SVF isolation technologies, including enzyme-free systems, automated processing devices, and closed-loop cell therapy solutions. Collaborations with hospitals, research institutions, and regulatory bodies facilitate market access and promote SVF adoption. Moreover, emphasis on clinical trials, evidence-based research, and patient awareness programs supports the expansion of SVF-based therapies in the regenerative medicine landscape.

Key Companies Profiled:

• Cytori Therapeutics
• Tissue Genesis, Inc.
• InGeneron, Inc.
• Celltex Therapeutics
• IntelliCell BioSciences, Inc.
• LifeCell International Pvt. Ltd.
• SVF Biosciences
• Lonza Group
• PromoCell GmbH
• RoosterBio, Inc.

Key Segments Covered in Manufacturing of Industry Research

By Product:

• SVF Aspiration Products
• SVF Transfer Products
• SVF Isolation Products

By Application:

• Cosmetic Applications
• Orthopedic Applications
• Soft Tissue Applications

By End User:

• Hospitals
• Specialty Clinics
• Stem Cell Banks/Laboratories

By Region:

• North America
• Latin America
• Europe
• South Asia and Oceania
• East Asia
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Stromal Vascular Fraction Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Product Adoption Analysis
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Global Stromal Vascular Fraction Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 4.3. Global Stromal Vascular Fraction Market Outlook: Product
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    • 4.3.3.1. SVF Aspiration Products
    • 4.3.3.2. SVF Transfer Products
    • 4.3.3.3. SVF Isolation Products
      • 4.3.3.3.1. Enzymatic Isolation Products
      • 4.3.3.3.2. Non-enzymatic Isolation Products
      • 4.3.3.3.3. Automated POC Devices
  • 4.3.4. Market Attractiveness Analysis: Product
• 4.4. Global Stromal Vascular Fraction Market Outlook: Application
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
  • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 4.4.3.1. Cosmetic Applications
    • 4.4.3.2. Orthopedic Applications
    • 4.4.3.3. Soft Tissue Applications
    • 4.4.3.4. Others
  • 4.4.4. Market Attractiveness Analysis: Application
• 4.5. Global Stromal Vascular Fraction Market Outlook: End User
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 4.5.3.1. Hospitals
    • 4.5.3.2. Specialty Clinics
    • 4.5.3.3. Stem Cell Banks/Laboratories
    • 4.5.3.4. Others
  • 4.5.4. Market Attractiveness Analysis: End User

5. Global Stromal Vascular Fraction Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Stromal Vascular Fraction Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By End User
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  • 6.4.1. SVF Aspiration Products
  • 6.4.2. SVF Transfer Products
  • 6.4.3. SVF Isolation Products
    • 6.4.3.1. Enzymatic Isolation Products
    • 6.4.3.2. Non-enzymatic Isolation Products
    • 6.4.3.3. Automated POC Devices
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 6.5.1. Cosmetic Applications
  • 6.5.2. Orthopedic Applications
  • 6.5.3. Soft Tissue Applications
  • 6.5.4. Others
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 6.6.1.
    • 6.6.1.1. Hospitals
    • 6.6.1.2. Specialty Clinics
    • 6.6.1.3. Stem Cell Banks/Laboratories
    • 6.6.1.4. Others
• 6.7. Market Attractiveness Analysis

7. Europe Stromal Vascular Fraction Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  • 7.4.1. SVF Aspiration Products
  • 7.4.2. SVF Transfer Products
  • 7.4.3. SVF Isolation Products
    • 7.4.3.1. Enzymatic Isolation Products
    • 7.4.3.2. Non-enzymatic Isolation Products
    • 7.4.3.3. Automated POC Devices
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.5.1. Cosmetic Applications
  • 7.5.2. Orthopedic Applications
  • 7.5.3. Soft Tissue Applications
  • 7.5.4. Others
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.6.1.
    • 7.6.1.1. Hospitals
    • 7.6.1.2. Specialty Clinics
    • 7.6.1.3. Stem Cell Banks/Laboratories
    • 7.6.1.4. Others
• 7.7. Market Attractiveness Analysis

8. East Asia Stromal Vascular Fraction Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  • 8.4.1. SVF Aspiration Products
  • 8.4.2. SVF Transfer Products
  • 8.4.3. SVF Isolation Products
    • 8.4.3.1. Enzymatic Isolation Products
    • 8.4.3.2. Non-enzymatic Isolation Products
    • 8.4.3.3. Automated POC Devices
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.5.1. Cosmetic Applications
  • 8.5.2. Orthopedic Applications
  • 8.5.3. Soft Tissue Applications
  • 8.5.4. Others
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.6.1.
    • 8.6.1.1. Hospitals
    • 8.6.1.2. Specialty Clinics
    • 8.6.1.3. Stem Cell Banks/Laboratories
    • 8.6.1.4. Others
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Stromal Vascular Fraction Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  • 9.4.1. SVF Aspiration Products
  • 9.4.2. SVF Transfer Products
  • 9.4.3. SVF Isolation Products
    • 9.4.3.1. Enzymatic Isolation Products
    • 9.4.3.2. Non-enzymatic Isolation Products
    • 9.4.3.3. Automated POC Devices
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.5.1. Cosmetic Applications
  • 9.5.2. Orthopedic Applications
  • 9.5.3. Soft Tissue Applications
  • 9.5.4. Others
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.6.1.
    • 9.6.1.1. Hospitals
    • 9.6.1.2. Specialty Clinics
    • 9.6.1.3. Stem Cell Banks/Laboratories
    • 9.6.1.4. Others
• 9.7. Market Attractiveness Analysis

10. Latin America Stromal Vascular Fraction Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  • 10.4.1. SVF Aspiration Products
  • 10.4.2. SVF Transfer Products
  • 10.4.3. SVF Isolation Products
    • 10.4.3.1. Enzymatic Isolation Products
    • 10.4.3.2. Non-enzymatic Isolation Products
    • 10.4.3.3. Automated POC Devices
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.5.1. Cosmetic Applications
  • 10.5.2. Orthopedic Applications
  • 10.5.3. Soft Tissue Applications
  • 10.5.4. Others
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.6.1. Hospitals
  • 10.6.2. Specialty Clinics
  • 10.6.3. Stem Cell Banks/Laboratories
  • 10.6.4. Others
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Stromal Vascular Fraction Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Application
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  • 11.4.1. SVF Aspiration Products
  • 11.4.2. SVF Transfer Products
  • 11.4.3. SVF Isolation Products
    • 11.4.3.1. Enzymatic Isolation Products
    • 11.4.3.2. Non-enzymatic Isolation Products
    • 11.4.3.3. Automated POC Devices
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.5.1. Cosmetic Applications
  • 11.5.2. Orthopedic Applications
  • 11.5.3. Soft Tissue Applications
  • 11.5.4. Others
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.6.1. Hospitals
  • 11.6.2. Specialty Clinics
  • 11.6.3. Stem Cell Banks/Laboratories
  • 11.6.4. Others
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Cytori Therapeutics Inc.
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. IntelliCell BioSciences Inc.
  • 12.3.3. Cellular Biomedicines Group, Inc.
  • 12.3.4. GE Healthcare (Biosafe Group SA)
  • 12.3.5. Lifecell Corporation (Allergen PLC)
  • 12.3.6. Tissue Genesis Inc.
  • 12.3.7. InGeneron, Inc.
  • 12.3.8. Human med AG
  • 12.3.9. MEDICAN CO., LTD
  • 12.3.10. Hairline International
  • 12.3.11. Genesis Biosystems, Inc.
  • 12.3.12. iXCells Biotechnologies USA, LLC
  • 12.3.13. Kyocera Corporation
  • 12.3.14. Medikan International Inc.
  • 12.3.15. Eurofins Scientific
  • 12.3.16. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations

관련자료